Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Chemistry
Class Information
Number: 530
Name: Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof >
Description:


Class Number Class Name No. of Patents
530/806

Antigenic peptides or proteins

641
530/800

Antihypertensive peptides

81
530/810

Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g., biological cell or cell fragment as carrier, etc.

241
530/811

Peptides or proteins is immobilized on, or in, an inorganic carrier

194
530/812

Peptides or proteins is immobilized on, or in, an organic carrier

266
530/813

Carrier is a saccharide

159
530/814

Cellulose or derivatives thereof

111
530/815

Carrier is a synthetic polymer

287
530/816

Attached to the carrier via a bridging agent

253
530/817

Entrapped within the carrier, e.g., gel, hollow fibre, etc.

63
530/802

Chromogenic or luminescent peptides

80
530/807

Hapten conjugated with peptide or protein

229
530/868

Involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

236
530/862

Involving ige or igd

47
530/861

Involving igg3, igg4, iga, or igy

108
530/863

Involving igm

51
530/864

Monoclonal

119
530/865

Human

35
530/866

Involving immunoglobulin or antibody fragment, (e.g., f(ab)'2, fab', fab, fv, fc, heavy chain, light chain, etc.)

234
530/867

Involving immunoglobulin or antibody produced via recombinant dna technology

69
530/500

Lignins or derivatives

115
530/501

Aldehyde, ketone or ozone reacted with a lignin or lignin containing substance, or product thereof

64
530/504

Carboxylic acid anhydride, or a compound having halogen bonded directly to acyclic carbon by nonionic bonding, reacted with a lignin or lignin containing substance, or product thereof

23
530/505

Compound containing nitrogen attached directly or indirectly to carbon by nonionic bonding reacted with a lignin or lignin containing substance, or product therof

32
530/502

Compound which includes phenolic hydroxy or oxygen containing hetero ring reacted with a lignin or lignin containing substance, or product thereof

49
530/506

Heavy metal, aluminum, silicon or phosphorus containing

39
530/503

Hydrogenation of a lignin or lignin containing substance, or product thereof

2
530/507

Processes utilizing an organic solvent or a compound having alcoholic hydroxy bonded directly to an acyclic carbon, or product thereof

40
530/808

Materials and products related to genetic engineering or hybrid or fused cell technology, e.g., hybridoma, monoclonal products, etc.

299
530/809

Fused cells, e.g., hybridoma, etc.

250
530/200

Natural resins or derivatives (e.g., wood or pine tar; cativo resin derivatives, etc.)

34
530/202

Cut wood starting material used in process, or product thereof (e.g., using pine stumps, chips, bark, etc., as starting material)

11
530/203

Plant sap or fossil starting material used in process, or product thereof (e.g., using copal, coal, amber, dammar, etc., as starting material)

10
530/204

Pine oleoresin starting material used in process, or product thereof (e.g., using gum turpentine, pine gum, pine resin, etc., as starting material)

9
530/205

Recovery of tall oil or derivatives from papermaking waste, purification of tall oil, or separation of components of tall oil; or product thereof (e.g., separation of rosin, fatty acids, sterols, etc.; decolorizing, etc.)

41
530/207

Esterification used in the process, or product thereof

9
530/208

Inorganic material used in the process, or product thereof (e.g., using sulfuric acid, boric acid, etc.)

31
530/209

Phosphorus or heavy metal containing material, elemental hydrogen, sulfur dioxide, or carbon dioxide used in the process, or product thereof

11
530/206

Organic sulfur or nitrogen containing material used in the process, or product thereof

11
530/210

Rosin or derivative used as starting material in process, or product thereof (e.g., using gum rosin, wood rosin, solid tall oil rosin, etc.)

56
530/213

Boron or phosphorus containing material used in the process, or product thereof

23
530/214

Diels-alder adducts (e.g., of maleic anhydride, fumaric acid, etc., with conjugated dienes, such as rosin acids, terpenes, etc.)

38
530/215

Esterification of rosin or derivative via carboxyl group, or product thereof

40
530/216

Chemical treatment or color modification of esterified rosin or derivative, or product thereof (e.g., partial saponification of rosin triglycerides; removal of color bodies from rosin esters, etc.)

25
530/217

Oxygen containing ring or halogen containing material used in the esterification, or product thereof (e.g., using alkylene oxides, polysaccharides, alkyl halides, etc.)

27
530/218

Polyhydroxy material used in the esterification, or product thereof (e.g., forming ester gum, etc.)

53
530/226

Heat treatment of rosin or derivative in the absence of nonrosin organic reactants, or product thereof (e.g., forming rosin oil; disproportionated, dehydrogenated, or isomerized rosin; etc.)

11
530/227

Metal, halogen, or silicon containing material used in the process, or product thereof (e.g., using clay, zeolites, etc.)

10
530/223

Hydrogenation or product thereof (e.g., forming dihydro rosin acids; rosinyl alcohol or derivatives; etc.)

12
530/224

Metal containing material used to form salts of rosin acids, or product thereof

13
530/225

Alkali metal containing material (i.e., li, na, k, rb or cs)

7
530/221

Nitrogen containing material used in the process, or product thereof

28
530/222

The nitrogen containing material is inorganic

4
530/211

Polymerization or product thereof (e.g., dimer rosin, etc.)

35
530/212

Chemical treatment or color modification of polymerized rosin or derivative, or product thereof (e.g., hydrogenation or esterification of polymerized rosin; removal of color bodies from polymerized rosin, etc.)

28
530/228

Purification process or product thereof

7
530/229

Immiscible solvents used in the process, or product thereof

2
530/219

Sulfur, selenium, or tellurium containing material used in the process, or product thereof (e.g., disproportionation of rosin, etc.)

17
530/220

The sulfur, selenium, or tellurium containing material is inorganic

10
530/201

Shellac containing starting material used in process, or product thereof (e.g., lac, sticklac, seedlac, flake shellac, bleached shellac, etc.)

10
530/230

Tall oil or derivative used as starting material in process, or product thereof (e.g., metal salts of tall oil fatty acids; tall oil pitch, etc.) dehydrogenated, or isomerized rosin; etc.)

45
530/232

Esterification of tall oil acids, or product thereof

27
530/231

Nitrogen containing material used in the process, or product thereof

17
530/233

Sulfur, boron, phosphorus, or iodine containing material used in the process, or product thereof

17
530/801

Peptide sweetners

57
530/300

Peptides of 3 to 100 amino acid residues

4979
530/327

11 to 14 amino acid residues in defined sequence

1906
530/326

15 to 23 amino acid residues in defined sequence

2337
530/325

24 amino acid residues in defined sequence

1000
530/324

25 or more amino acid residues in defined sequence

3638
530/330

4 to 5 amino acid residues in defined sequence

1740
530/329

6 to 7 amino acid residues in defined sequence

1586
530/328

8 to 10 amino acid residues in defined sequence

2190
530/316

Angiotensin; related peptides

61
530/314

Bradykinin; kallidin; related peptides

66
530/307

Calcitonin; related peptides

179
530/345

Chemical aftertreatment, e.g., acylation, methylation, etc.

859
530/332

Containing at least one abnormal peptide link, e.g., gamma peptide bonded, etc.

316
530/306

Corticotropin (atch); related peptides

59
530/317

Cyclic peptides

1199
530/320

Bacitracin; related peptides

32
530/321

Containing only normal peptide links in the ring, i.e., homodetic cyclic peptides

203
530/318

The cyclisation occurring through the 4-amino radical of 2,4-diamino butanoic acid

49
530/319

Polymyxin; related peptides

22
530/302

Endorphin and enkephalin; related peptides

177
530/308

Glucagon; related peptides

145
530/310

Gramicidin or tyrocidin; related peptides

8
530/303

Insulin; related peptides

485
530/305

Isolation or purification

96
530/304

Metal complexes, e.g., zn-insulin, etc.

92
530/313

Lutenizing hormone releasing factor (lrf); related peptides

264
530/312

Melanotropin (msh) or eledoisin; related peptides

38
530/315

Oxytocin; vasopressin; related peptides

91
530/322

Peptides containing saccharide radicals, e.g., bleomycins, etc.

519
530/323

Peptides with at least one nonpeptide bond other than a disulfide bond joining two or more sequences of amino acid residues, e.g., homomeric heterodectic peptide other than cyclic disulfide, depsipeptides, etc.

393
530/309

Secretin or gastrin; related peptides

48
530/344

Separation or purification

456
530/311

Somatostatin (srif); related peptides

269
530/333

Synthesis of peptides

723
530/343

By hydrolysis

81
530/334

Polymer supported synthesis, e.g., solid phase synthesis, merrifield synthesis, etc.

589
530/335

Protecting or removing protective groups, e.g., carboxyl group protection, etc.

221
530/337

Of amino group

146
530/336

Of side chain or sulfur containing group

127
530/338

Solution phase synthesis

189
530/342

Mixed anhydride synthesis

25
530/339

Segment condensation, e.g., ugi condensation, etc.

76
530/340

With phosphorus containing material

29
530/341

With use of carbonimide or imidiazole

27
530/301

Thymopoietin or lipotropin; related peptides

42
530/331

Tripeptides, e.g., tripeptide thyroliberin (trh), melanostatin (mif), etc.

1473
530/855

Proteins from animals other than mammals or birds

64
530/857

Fish; fish eggs; shell fish; crustacea

83
530/858

Insects; venom

75
530/856

Snakes; venom

35
530/827

Proteins from mammals or birds

132
530/829

Blood

243
530/830

Plasma; serum

347
530/831

Cohn fractions

86
530/840

Bones; tendons; teeth; cartilage

109
530/828

Cancer

262
530/843

Digestive system

10
530/847

Bile

1
530/846

Liver

25
530/845

Pancreas

15
530/844

Stomach; intestine

14
530/849

Eyes; vessels; umbilical cord

12
530/854

Glands

49
530/848

Lungs

25
530/837

Lymph; lymph-glands; thymus

45
530/838

Marrow; spleen

30
530/832

Milk; colostrum

96
530/836

Mucus; mucous glands; bursa; arthral fluid; spinal fluid

6
530/841

Muscles; heart

34
530/839

Nerves; brain

73
530/850

Reproductive organs or embryos

47
530/851

Placenta; amniotic fluid

83
530/852

Sperm

22
530/853

Ovary; eggs; embryos

57
530/842

Skin; hair; nails; sebaceous glands; cerumen

43
530/834

Urine; urinary system

48
530/835

Kidney

22
530/833

Whey; cheese

92
530/820

Proteins from micro-organisms

158
530/825

Bacteria

544
530/823

Lower fungi, e.g., mold, etc.

36
530/824

Yeasts

76
530/822

Protozoa

64
530/821

Separation of nucleic acid

34
530/826

Viruses

277
530/350

Proteins, i.e., more than 100 amino acid residues

13520
530/362

Albumin

237
530/365

Lactalbumin, e.g., milk source, etc.

62
530/366

Separation, purification or synthesis

67
530/367

Ovalalbumin, e.g., avidin, conalbumins, etc.

75
530/368

Separation, purification or synthesis

16
530/369

Separation, purification or synthesis

28
530/363

Serum albumin, e.g., bsa, hsa, etc.

452
530/364

Separation, purification or synthesis

168
530/380

Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc.

961
530/381

Blood coagulation factors and fibrin, e.g., thromboplastin, etc.

467
530/384

Blood coagulation factor ii or factor ii + vii + ix + x, i.e., prothrombin complex or factor

262
530/383

Blood coagulation factor viii, ahf

386
530/382

Fibrin or fibrin intermediates, e.g., fibrinogen, etc.

291
530/386

Globulins

220
530/392

Alpha globulins, e.g., ceruloplastin, haptoglobins, etc.

97
530/393

Antithrombin iii

53
530/394

Beta globulins, e.g., transferrin, etc.

95
530/387.1

Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed

2947
530/387.2

Anti-idiotypic

203
530/387.7

Binds expression product of cancer-related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.)

564
530/387.5

Binds oligosaccharide structure

188
530/387.9

Binds specifically-identified amino acid sequence

1423
530/387.3

Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rfv, immunoglobulin fusion protein, etc.)

2008
530/388.1

Monoclonal

2173
530/388.9

Binds drug, hapten, hapten--carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.)

282
530/388.2

Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.)

890
530/388.4

Binds bacterium or similar microorganism or component or product thereof (e.g., stretococcus, legionella, mycoplasma, bacterium-associated antigen, exotoxin, etc.)

297
530/388.8

Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.)

739
530/388.85

Binds antigen characterized by name or molecular weight (e.g., cea, nca, cc glycoprotein, melanoma gp 150 antigen, etc.)

705
530/388.26

Binds enzyme

317
530/388.5

Binds fungus or plant cell or component or product thereof (e.g., fungus-associated antigen, etc.)

65
530/388.7

Binds hematopoietic cell or component or product thereof (e.g., erythrocyte granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell-surface antigen, hemoglobin, thrombospondin, glycophorin, etc.)

458
530/388.73

Binds lymphocytic or lymphocytic-like cell or component or product thereof (e.g., b cell, b-lineage bone marrow cell, null cell, natural killer cell, b-lymphoblastoid cell, b-lineage acute lymphoblastic leukemia cell, b-lymphocytic cell-surface antigen, etc.)

384
530/388.75

Binds t-lymphocytic cell or component or product thereof (e.g., t cell, thymocyte, t-lineage bone marrow cell, t-lymphoblastoid cell, t-lineage acute lymphoblastic leukemia cell, t-lymphocytic cell-surface antigen, etc.)

389
530/388.24

Binds hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, intragonadal regulatory protein, mullerian inhibiting substance, inhibin, epidermal growth factor, nerve growth factor, dopamine, norepinephrine, etc.)

391
530/388.23

Binds lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator specific for a hematopoietic cell (e.g., interleukin, interferon, erythropoietin, etc.)

509
530/388.21

Binds nucleic acid or derivative or component thereof (e.g., dna, rna, dna-rna hybrid, nucleotide, nucleoside, carcinogen-dna adduct, etc.)

61
530/388.6

Binds parasitic protozoan or metazoan cell or component or product thereof (e.g., dirofilaria, eimeria, coccidia, trichinella, parasite cell-surface antigen, etc.)

112
530/388.25

Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)

426
530/388.22

Binds receptor (e.g., transferrin receptor, fc receptor, dihydropyridine receptor, il-2 receptor, etc.)

1071
530/388.3

Binds virus or component or product thereof (e.g., virus-associated antigen, etc.)

261
530/388.35

Binds retrovirus or component or product thereof (e.g., hiv, lav, htlv, etc.)

175
530/388.15

Human

580
530/389.1

Polyclonal antibody or immunogloblin of identified binding specificity

966
530/389.5

Binds bacterium or similar microorganism or component or product thereof (e.g., pseudomonas, chlamydia, clostridium, bacterium-associated antigen, etc.)

204
530/389.7

Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.)

342
530/389.8

Binds drug, hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.)

346
530/389.6

Binds hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, bone marrow cell, lymphocyte, leukemic cell, hematopoietic cell-surface antigen, hemoglobin, etc.)

213
530/389.2

Binds hormone, lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, glucagon, cardiodilatin, interleukin, interferon, norepinephrine, epinephrine, acetylcholine, etc.)

467
530/389.3

Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)

274
530/389.4

Binds virus or component or product thereof (e.g., virus-associated antigen, etc.)

220
530/390.1

Removing or inactivating virus or bacterium or component or product thereof (e.g., endotoxin, etc.)

107
530/390.5

Removing, dissociating, or preventing the formation of aggregated, denatured, fragmented, or polymerized immunoglobulin or antibody; or preventing or reducing complement fixation or binding; or reducing antigenicity; or removing, inactivating, or inhibiting contaminating plasma proteins (e.g., proteolytic enzymes, etc.)

126
530/391.1

Monoclonal or polyclonal antibody or immunoglobulin or fragment thereof that is conjugated or adsorbed (e.g., adsorbed to a solid support, etc.)

879
530/391.7

Conjugated to a cytotoxic agent, drug, or other biologically-active substance

623
530/391.9

Conjugated via a specifically-identified linking group, coupling agent, or conjugation agent

299
530/391.3

Conjugated to a detectable label or radioisotope or radionuclide or heavy metal-containing compound

1022
530/391.5

Conjugated via a specifically-identified linking group, chelating group, coordination complex, coupling agent, or conjugation agent

393
530/385

Hemoglobins or globins

415
530/360

Casein or caseinate

126
530/361

Separation, purification or synthesis

70
530/402

Chemical modification or the reaction product thereof, e.g., covalent attachment or coupling, etc.

1746
530/407

Hydrolysis of protein

133
530/409

Nitrogen containing reactant

498
530/410

Oxygen containing reactant

330
530/411

Oxygen containing is saccharide

84
530/403

Protein is identified as an antigen, e.g., immunogenic carriers, etc.

848
530/405

Nitrogen containing reactant

584
530/406

Oxygen containing reactant

282
530/404

Sulfur containing reactant

322
530/408

Sulfur containing reactant

353
530/395

Glycoprotein, e.g., mucins proteoglycans, etc.

1647
530/397

Glycoprotein hormones

321
530/398

Gonadatropins

130
530/396

Lectins, e.g., concanavalin, hemagglutinin, etc.

136
530/399

Hormones, e.g., prolactin, thymosin, growth factors, etc.

1782
530/359

Lipoproteins, e.g., egg yolk proteins, cylomicrons, etc.

184
530/351

Lymphokines, e.g., interferons, interlukins, etc.

2191
530/400

Metal containing, e.g., chromoproteins, ferritin, ferredoxins, etc.

185
530/401

Cytochromes, e.g., chlorophyl, orgotein, etc.

37
530/358

Nucleoproteins, e.g., chromatin, chromosomal proteins, histones, protamines, salmine, etc.

220
530/352

Phosphoproteins, e.g., phosvitin, vitellogenin, etc.

128
530/370

Plant proteins, e.g., derived from legumes, algae or lichens, etc.

742
530/371

Derived from fungi, e.g., yeasts, mushroom, etc.

128
530/372

Derived from grain, e.g., prolamines, etc.

106
530/376

Derived from corn

68
530/375

Derived from wheat

76
530/374

Gluten or gliadin

74
530/373

Zein

32
530/379

Derived from leafy green plants, e.g., alfalfa pollen, etc.

128
530/377

Derived from oil seed, e.g., cotton seed, rapeseed, sunflower, etc.

180
530/378

Derived from soybean

238
530/353

Scleroproteins, e.g., fibroin, elastin, silk, etc.

118
530/356

Collagen

542
530/354

Gelatin

222
530/355

Separation, purification or synthesis

84
530/357

Keratin

82
530/412

Separation or purification

1378
530/413

Immunological separation or affinity chromatography

1133
530/427

Physical treatment

321
530/418

Precipitation

288
530/419

With added material

222
530/420

Inorganic

201
530/421

Polymeric, e.g., polyethylene glycol, etc.

124
530/415

Selective absorbtion, e.g., ca phosphate sorbents, etc.

338
530/417

Chromatography or by septum selective as to material, e.g., gel filtration, molecular sieve dialysis, etc.

761
530/416

Ion exchange

641
530/422

Solvent extraction

205
530/426

Hydrocarbon or halogenated hydrocarbon

27
530/423

Oxygenated material

68
530/424

Alcohol

81
530/425

Carboxyl containing

39
530/414

Ultra filtration or osmosis

273
530/860

Renin inhibitors

134
530/859

Waste, waste material, refuse or sludge, e.g., effluents, fecal matter, etc.

40
 
 
  Recently Added Patents
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
Photovoltaic component and production method therefor
Vehicle seat with movable cushion portion
Method of manufacturing semiconductor device having side wall spacers
Orientation device and method for coordinate generation employed thereby
Bypass valve with an integral flow sensor for a water treatment system
Telescoping leg
  Randomly Featured Patents
Transformed current sensing relay for use in switched network modems and circuit incorporating same
Method and apparatus for accommodating TDM traffic in an ethernet passive optical network
Rotary damper
Short dwell coater apparatus with backing blanket disposed between blade and guide roll
Power boat
Method and apparatus for calibrating a mass air flow sensor using an oscillating air flow
Control method of sliding a vehicle door by a powered sliding device
Insulating crystals for coating on a metal mesh of a storage tube
Sheet guide device with sheet position adjusting mechanism and image forming apparatus using the same device
Battery constructions and method for forming such battery constructions